Biosimilarity: the FDA perspective
Book information
Description
Content: Understanding proteins -- The biosimilars landscape -- The FDA regulatory guidance -- Understanding biosimilarity -- Biopharmaceutical tools -- Critical quality attributes -- Safety similarity -- Formulation similarity -- Statistical modeling -- Biosimilarity : the final frontier.
Similar books
Handbook of pharmaceutical manufacturing formulations Volume 3
2020 · PDF
Handbook of pharmaceutical manufacturing formulations Volume 1
2020 · PDF
Biosimilars and interchangeable biologics. Tactical elements
2016 · PDF
Biosimilars and interchangeable biologics: strategic elements
2016 · PDF
Biosimilars and interchangeable biologics. Tactical elements
2016 · PDF
Handbook of Preformulation : Chemical, Biological, and Botanical Drugs, Second Edition
2019 · PDF
Handbook of Pharmaceutical Manufacturing Formulations, Vol 6 Sterile Products
2009 · PDF
Handbook of Pharmaceutical Manufacturing Formulations, Vol 4 Semisolid Products
2009 · PDF